3 completed, 3 recruiting, 1 suspended, 1 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Anxiety Disorder Generalized: new trials by email Literature Review of Anxiety Disorder Generalized trials Research Report on Anxiety Disorder Generalized
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ACT for Individuals With MNCD and Their Care Partners Acceptance Commitment Therapy - Depression in Adults, Anxiety Disorder Generalized | Phase 1 | Recruiting | Texas Tech University | 100 | 2026-04-01 | 2026-05-15 |
| Digital Single-Session Cognitive Behavioural Therapy in Healthy Adults Digital single-session cognitive behavioural therapy, Digital memory task - Depression / Major Depressive Disorder, Anxiety | Not applicable | Completed | Brunel University | 110 | 2024-07-23 | 2026-10-14 |
| Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device Prescription Psychotropic Medications - ADHD, Depression Disorders | Recruiting | Gaize | 50 | 2024-04-17 | 2026-02-05 | |
| A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder CD-008-0045, Placebo, Afobazol - Anxiety Disorder Generalized | Phase 3 | Unknown | ChemRar Research and Development Institute, LLC | 200 | 2020-12-01 | 2020-10-22 |
| CBT and the Neural Circuits of Anxiety Cognitive Behavioural Therapy, Waiting List - Generalised Anxiety Disorder, Anxiety Disorders | Recruiting | UCLH/UCL Joint Research Office | 174 | 2020-02-02 | 2025-06-29 | |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease There is no intervention in this study - Gut Microbiome, Gastrointestinal Microbiome | Suspended | ProgenaBiome | 1000 | 2019-07-11 | 2026-09-21 | |
| А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder CD-008-0045, Placebo - Anxiety Disorder Generalized | Phase 2 | Completed | ChemRar Research and Development Institute, LLC | 129 | 2018-10-02 | 2020-08-24 |
| Mindfulness-Based Psychoeducation With Substance Use and Anxiety Disorders Mindfulness-Based Psychoeducation Program - Substance Use Disorder (SUD), Anxiety Disorder Generalized | Completed | Bout Me Healing | 3 | 2016-03-13 | 2026-03-19 |
Generalized Anxiety Disorder (8) · Anxiety Disorders (4) · Bipolar Disorder (2) · Depression (2) · Depressive Disorder, Major (2) · Acne Vulgaris (1) · Alzheimer Disease (1) · Amyotrophic Lateral Sclerosis (1) · Arthritis, Rheumatoid (1) · Attention Deficit Disorder with Hyperactivity (1) · Autism Spectrum Disorder (1) · Autistic Disorder (1) · Bipolar and Related Disorders (1) · Celiac Disease (1) · Colitis, Ulcerative (1)
Mental Disorders (8) · Anxiety Disorders (4) · Behavior (2) · Behavioral Symptoms (2) · Depressive Disorder (2) · Immune System Diseases (2) · Mood Disorders (2) · Neoplasms by Histologic Type (2) · Neurodevelopmental Disorders (2) · Acneiform Eruptions (1) · Adenoma (1) · Arthritis (1) · Attention Deficit and Disruptive Behavior Disorders (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1)
2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole (1) · Acceptance and Commitment Therapy (1) · Cognitive Behavioral Therapy (1) · Salvage Therapy (1) · Waiting Lists (1)
ChemRar Research and Development Institute, LLC (2) · Bout Me Healing (1) · Brunel University (1) · Gaize (1) · ProgenaBiome (1) · Texas Tech University (1) · UCLH/UCL Joint Research Office (1)
United States (4) · United Kingdom (2) · Russia (1)
Margarita A Morozova, MD,PhD,Prof (2) · Cice Rivera, MS, CAP (1) · Sabine Hazan, MD (1)